DRIVER FATIGUE.

SEC. 4021. DRIVER FATIGUE. (a) Technologies To Reduce Fatigue of Commercial Motor Vehicle Operators.— (1) Development of technologies.— As part of the activities of the Secretary relating to the fatigue of commercial motor vehicle operators, the Secretary shall encourage the research, development, and demonstration of technologies that may aid in reducing such fatigue. 112 STAT. 415 (2) Matters to be taken into account.— In carrying out paragraph (1), the Secretary shall take into account— (A) the degree to which the technology will be cost efficient; (B) the degree to which the technology can be effectively used in diverse climatic regions of the Nation; and (C) the degree to which the application of the technology will further emissions reductions, energy conservation, and other transportation goals. (3) Funding.— The Secretary may use amounts made available under section 5001(a)(2) of this Act. (b) Nonsedating Medications.— The Secretary shall review available information on the effects of medications (including antihistamines) on driver fatigue, awareness, and performance and shall consider encouraging, if appropriate, the use of nonsedating medications (including nonsedating antihistamines) as a means of reducing the adverse effects of the use of other medications by drivers.